deltatrials
Unknown PHASE1 INTERVENTIONAL 2-arm NCT02694653

Preoperative Cesarean Section Intravenous Acetaminophen and Postoperative Pain Control

Preoperative Cesarean Section Intravenous Acetaminophen and Postoperative Pain Control: A Blinded Randomized Placebo-Controlled Trial

Sponsor: University of Tennessee Graduate School of Medicine

Updated 7 times since 2017 Last updated: Apr 18, 2017 Started: Oct 31, 2014 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02694653, this PHASE1 trial focuses on Complications; Cesarean Section and remains ongoing. Sponsored by University of Tennessee Graduate School of Medicine, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotEnrolling By Invitation~May 2017 – ~Jun 2018 · 13 months · monthly snapshotEnrolling By Invitation~Jun 2018 – ~May 2019 · 11 months · monthly snapshotEnrolling By Invitation~May 2019 – ~Jan 2021 · 20 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 21 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1

  4. May 2019 — Jan 2021 [monthly]

    Unknown Status PHASE1

    Status: Enrolling By InvitationUnknown Status

  5. Jun 2018 — May 2019 [monthly]

    Enrolling By Invitation PHASE1

Show 2 earlier versions
  1. May 2017 — Jun 2018 [monthly]

    Enrolling By Invitation PHASE1

  2. Jan 2017 — May 2017 [monthly]

    Enrolling By Invitation PHASE1

    First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Tennessee Graduate School of Medicine
Data source: University of Tennessee Graduate School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.